| Warrants - Summary of Information Assuming Warrants are Exercised and Exchanged for Common Shares (Details) - Series B Convertible Preferred Stock Warrants - USD ($) $ / shares in Units, $ in Thousands | 9 Months Ended | 12 Months Ended | 
|---|---|---|
| Jun. 30, 2020 | Sep. 30, 2019 | |
| Class Of Warrant Or Right [Line Items] | ||
| Outstanding and Exercisable, Number of Common Shares to be Issued | 590,147 | 590,147 | 
| Outstanding and Exercisable, Weighted Average Exercise Price Per Common Share | $ 4.16 | $ 4.16 | 
| Outstanding and Exercisable, Weighted Average Remaining Contractual Term (in years) | 1 year 7 months 6 days | 6 months 10 days | 
| Outstanding and Exercisable, Intrinsic Value | $ 3,151 | $ 2,602 | 
| X | ||||||||||
| 
- Definition Warrants outstanding and exercisable, intrinsic value. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Weighted average exercise price per common share of warrants outstanding and exercisable. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Weighted average remaining contractual term warrants outstanding and exercisable. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Details 
 |